Podcast:Considerations in ophthalmic formulation development for various ocular diseases

Podcast

Sponsored Content

Considerations in Ophthalmic Formulation Development for Various Ocular Diseases

Sponsored By

For more than 10 years, Dow has been intimately involved in ophthalmic formulation development for various ocular diseases such as cataract, ocular hyphema, dry-eye, age-related macular degeneration, glaucoma, etc. This podcast will attempt to share such ophthalmic formulation technology with the scientists and formulators who are interested in developing eye-care products.

WHITEPAPERS



Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18